Response to Comments: Platelet Rich Plasma

This notice documents the response to comments for the Platelet Rich Plasma LCD L38745; no provider comments were received during the comment period. The LCD's public notice period begins 12/24/2020 and the determination becomes effective 2/7/2021; the document does not specify any clinical coverage criteria changes.

"No provider comments were received during the LCD L38745 comment period (9/3/2020–11/7/2020); the notice period for LCD L38745 begins 12/24/2020 and the LCD becomes effective 2/7/2021."

Sign up to see full coverage criteria, indications, and limitations.